QurieGen

📍 Nijmegen, Netherlands🗓 Founded 2022👥 9 employees💰 Last funded Apr 2025
QurieGen is a Dutch techbio company building “Google Maps for cells” to derisk and accelerate drug discovery and development. Our secret sauce is the data and models. We generate proprietary single-cell multi-omics data using our in-house built technologies, and we feed this unique, high-resolution dataset into our AI models. This allows us to build mechanistic, interpretable virtual cell models that simulate how signals move through pathways and predict how drugs reshape cellular systems. Because we control both the data layer and the modeling layer, we can go far beyond black-box predictions.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2022
Founded
Investor geography3 countries
Netherlands
1
Czech Republic
1
Poland
1
Investor activity2022–2025 · investors recorded per year
202212024120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in QurieGen?
QurieGen has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did QurieGen last raise funding?
The most recent investment in QurieGen recorded on gritt.io was in April 2025.
When was QurieGen founded?
QurieGen was founded in 2022.
What industry is QurieGen in?
QurieGen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is QurieGen based?
QurieGen is headquartered in Nijmegen, Netherlands.